STAGE IV NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IV NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IV NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CRISPR-Engineered immune cells aim to fight lung cancer
Disease control TerminatedThis study planned to test a new treatment for people with metastatic non-small cell lung cancer. Doctors would take immune cells from the patient's tumor, use CRISPR gene editing to boost their cancer-fighting ability, and then return them to the patient. The trial was withdrawn…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Experimental cocktail targets tough lung cancer
Disease control OngoingThis early-phase study tests a combination of two drugs, ceritinib and docetaxel, in people with advanced non-small cell lung cancer that does not have certain genetic markers (ALK-negative, EGFR wild-type). The main goal is to find the safest dose and see if the combination can …
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New hope for advanced lung cancer: adding local treatment may extend life
Disease control OngoingThis study tests whether adding local treatments like radiation or surgery to standard maintenance chemotherapy helps people with stage IV non-small cell lung cancer live longer without the disease getting worse. About 218 participants are randomly assigned to receive either main…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 12, 2026 12:02 UTC
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new drug (sEphB4-HSA) combined with standard chemotherapy in people with advanced or metastatic solid tumors, including head and neck, pancreatic, lung, and gallbladder cancers. The goal is to find the best dose and check for side effects. About 61 …
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 03, 2026 12:03 UTC
-
Blood test could predict which cancer treatments work best
Knowledge-focused OngoingThis study aims to develop a blood test that can predict how well cancer treatments will work for people with advanced (stage IV) lung cancer or melanoma. Researchers will analyze blood samples from 10,000 participants before and during treatment to find patterns that indicate wh…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Sponsor: OncoHost Ltd. • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC